| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |